A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers
Files
Publication date
2023-10-21
Authors
de Brouwer, Remco
te Rijdt, Wouter P.
Hoorntje, Edgar T.
Amin, Ahmad
Asselbergs, Folkert W
Cox, Moniek G.P.J.
Van Der Heijden, Jeroen F.
Hillege, Hans
Karper, Jacco C.
Mahmoud, Belend
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Keywords
Cardiomyopathy, Eplerenone, Fibrosis, Heart failure, Phospholamban, Randomized clinical trial, Cardiology and Cardiovascular Medicine
Citation
de Brouwer, R, te Rijdt, W P, Hoorntje, E T, Amin, A, Asselbergs, F W, Cox, M G P J, van der Heijden, J F, Hillege, H, Karper, J C, Mahmoud, B, van der Meer, P, Oomen, A, te Riele, A S J M, Silljé, H H W, Tan, H L, van Tintelen, J P, van Veldhuisen, D J, Westenbrink, B D, Wiesfeld, A C P, Willems, T P, van der Zwaag, P A, Wilde, A A M, de Boer, R A & van den Berg, M P 2023, 'A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers', European heart journal, vol. 44, no. 40, pp. 4284-4287. https://doi.org/10.1093/eurheartj/ehad292